Hackaday editors Elliot Williams and Mike Szczys stomp through a forest full of highly evolved hardware hacks. This week seems particularly plump with audio-related projects, like the thwack-tackular soldenoid typewriter simulator. But it’s the tape-loop scratcher that steals our hearts; an instrument that’s kind of two-turntables-and-a-microphone meets melloman. We hear the clicks of 10-bit numbers falling into place in a delightful adder, and follow it up with the beeps and sweeps of a smartphone-based metal detector.
Direct download (~60 MB)
Places to follow Hackaday podcasts:
Continue reading “Hackaday Podcast 066: The Audio Overdub Episode; Tape Loop Scratcher, Typewriter Simulator, And Relay Adder”
Nowadays, we still rely on medical records to tell when our last vaccinations were. For social workers in developing countries, it’s an incredibly difficult task especially if there isn’t a good standard in place for tracking vaccinations already.
A team at the Massachusetts Institute of Technology may be providing a solution – they’ve developed a safe ink to be embedded into the skin alongside the vaccine, only visible under a special light provided by a smartphone camera app. It’s an inconspicuous way to document the patient’s vaccination history directly into their skin and low-risk enough to massively simplify the process of maintaining medical records for vaccines.
Continue reading “Tracking Vaccination History With Invisible Tattoos”
In the early 1950s, the only thing scarier than the threat of nuclear war was the annual return of polio — an easily-spread, incurable disease that causes nerve damage, paralysis, and sometimes death. At the first sign of an outbreak, public hot spots like theaters and swimming pools would close up immediately.
One of the worst polio epidemics in the United States struck in 1952, a few years into the postwar baby boom. Polio is more likely to infect children than adults, so the race to create a vaccine reached a fever pitch.
Most researchers were looking into live-virus vaccines, which had worked nicely for smallpox and rabies and become the standard approach. But Jonas Salk, a medical researcher and budding virologist, was keen on the idea of safer, killed-virus vaccines. He believed the same principle would work for polio, and he was right. Within a few years of developing his vaccine, the number of polio cases in the United States dropped from ~29,000 in 1955 to less than 6,000 in 1957. By 1979, polio had been eradicated in the US.
Jonas Salk is one of science’s folk heroes. The polio vaccine was actually his sophomore effort — he and Thomas Francis developed the first influenza vaccine in the 1940s. And he didn’t stop with polio, either. Toward the end of his life, Salk was working on an AIDS vaccine.
Continue reading “Jonas Salk, Virologist And Vaccination Vanguard”
Oddly, there’s been a few recent outbreaks of measles. It struck me how when I was a kid, a few hundred kids getting measles wouldn’t have been news at all. However, even a handful makes the news now, since in 2000 the Center for Disease Control declared measles eradicated in the United States.
So how can an eradicated disease come back? How did we eradicate it to start with? The answers tell a pretty interesting tale of science applying to everyday life.
Continue reading “Better Living Through Science: Why Your Kids Probably Aren’t Getting Measles”
Being a cop’s kid leaves you with a lot of vivid memories. My dad was a Connecticut State Trooper for over twenty years, and because of the small size of the state, he was essentially on duty at all times. His cruiser was very much the family vehicle, and like all police vehicles, it was loaded with the tools of the trade. Chief among them was the VHF two-way radio, which I’d listen to during long car rides, hearing troopers dispatched to this accident or calling in that traffic stop.
One very common call was the blood relay — Greenwich Hospital might have had an urgent need for Type B+ blood, but the nearest supply was perhaps at Yale-New Haven Hospital. The State Police would be called, a trooper would pick up the blood in a cooler, drive like hell down I-95, and hand deliver the blood to waiting OR personnel. On a good day, a sufficiently motivated and skilled trooper could cover that 45-mile stretch in about half an hour. On a bad day, the trooper might end up in an accident and in need of blood himself.
Continue reading “Automate The Freight: Medical Deliveries By Drone”
We hear a lot about drone surveillance, drone package delivery, drone this, and drone that. Honestly, though, the best use of drones has been taking cool aerial videos and posting them online. Until now.
The US Fish and Wildlife Service plans to cover acres upon acres of prairie-dog habitat with vaccine-laced, peanut-butter coated M&Ms. The snacks also include a dye that will show up in the whiskers of prairie dogs that take the bait, allowing scientists to assess the efficacy of the program. And this is all in the name of saving endangered black-footed ferrets which share burrows with the prairie dogs. It seems they were getting the plague from the prairie dogs.
The quads are outfitted with a “glorified gumball machine” that spreads the vaccine tidbits around. Why a quad? They can cover more space with less disruption to the animals’ habitat. That’s a great application in our book.
But if you think this is a case of the USF&WS showing outrageous innovation, consider the way rabies was all but eliminated in Europe: throwing hundreds of thousands of vaccine-doped chicken heads out of helicopters across France, Switzerland, and Germany. You couldn’t make this up.
(Via [Popular Science], where the title is even more clickbaity than ours. Get it? “Clickbait”?)
Headline image: US Fish and Wildlife Service Mountain-Prairie
When we think of machine learning it’s usually in the context of robotics—giving an algorithm a large set of input data in order to train it for a certain task like navigation or understanding your handwriting. But it turns out you can also train a nasty virus to go to sleep and never wake up again. That’s exactly what the Immunity Project has been doing. They believe that they have a viable HIV vaccine and are trying to raise about $25 million to begin human testing.
The vaccine hacks the Human Immunodeficiency Virus itself, forcing it to mutate into a dormant form that will not attack its human carrier. It sounds so simple, but a lot of existing knowledge and procedures, as well as new technology, went into getting this far. Last week we spoke with [Reid Rubsamen, M.D.] about the process, which began by collecting blood samples from a wide range of “Controllers“. Controllers are people who carry HIV but manage to suppress the virus’s progression to AIDS. How do you find these people? That’s another story which Scientific American covered (PDF); the short answer is that thanks to the work of [Bruce D. Walker, M.D.] there was already a database of Controllers available.
The information accumulated by [Walker] then underwent a data crunching exercise. The data set was so enormous that a novel approach was adopted. For the laymen this is described as a spam filter: using computers to look at large sets of email to develop a complex process for sifting real messages out of the noise. The task at hand is to look at the genotype of a Controller and compare it with the epitope— a short chain of proteins—in the virus they carry. The power of machine learning managed to whittle down all the data to a list of the first six epitopes that have the desired dormant-mutation property. The vaccine consists of a cocktail of these epitopes. It does, however, require some clever delivery tactics to reach the parts of the world where it’s most needed. The vaccine must not require refrigeration nor any special skills to administer.
The vaccine’s production uses existing methods to synthesize the amino acid peptides, which are the epitopes themselves. The packaging, however, is a new concept. [Dr. Rubsamen’s] company, Flow Parma, Inc., is using microspheres to encapsulate the vaccine, which render it shelf-stable and allow it to be administered through a nasal spray. Learn more about the technology behind the production of microspheres from this white paper (PDF).
If the vaccine (which will be produced without profit) passes clinical trials, it could see mass distribution as early as 2017.
The $25M we mentioned earlier is a tall hill to climb, but think of the reward if the vaccine is successful. You can donate directly to help reach this goal. If you’re planning on giving gift cards this year, you can purchase them for many different retailers through Gyft, who is donating 100% of December proceeds to the project.